Forbes November 14, 2024
Joshua P. Cohen

In June, the Supreme Court overturned the decades-old Chevron doctrine that empowered a federal agency’s “reasonable interpretation of ambiguous federal laws.” This ruling could constrain regulatory agencies, specifically with respect to their latitude in interpreting and operationalizing laws as they see fit.

Since 1984, the Chevron doctrine has served as a framework for federal courts in deciding disputes between federal agencies and private parties over the legality of executive branch decisions and statutory regulations. For example, Congress has granted the Centers for Medicare and Medicaid Services considerable discretion in making policy decisions based on laws that were passed in Congress.

To illustrate, under the Inflation Reduction Act, CMS has been given the authority to select and then negotiate the prices...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Regulations
Surgeons Billed $2 Billion for Unnecessary Spine Surgeries: Report
AARP’s new CEO aims to protect Social Security and Medicare and make healthcare more affordable
How Medicaid Agencies Are Building Medicare Knowledge to Advance Health Equity
States ranked by total Medicare Part D enrollment
Let The Numbers Speak: Prescription Drug Provisions In The Inflation Reduction Act

Share This Article